ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Impact Associated With Pertuzumab and Trastuzumab SC and IV Formulations Utilization in Metastatic HER2-Positive Breast Cancer Patients Treated in Brazilian SUS
Nov 18, 2024, 10:30 AM
«
3101
3102
(current)
3103
3104
3105
3106
3107
3108
3109
3110
»